Yong, K. L., Hinsley, S., Auner, H. W., Bygrave, C., Kaiser, M. F., Ramasamy, K., de Tute, R. M., Sherratt, D., Flanagan, L., Garg, M., Hawkins, S., Williams, C., Cavenagh, J., Rabin, N. K., Croft, J., Morgan, G., Davies, F., Owen, R. G. and Brown, S. R. (2021) “Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: results from a multicenter, phase II, randomized, controlled trial (MUK<i>five</i&gt;)”, Haematologica. Pavia, Italy, 106(10), pp. 2694-2706. doi: 10.3324/haematol.2021.278399.